Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
57.01 CAD | -0.42% | -4.31% | -5.11% |
Dec. 11 | Goldman Sachs Downgrades Magna International to Sell From Neutral, CA$58 Price Target | MT |
Dec. 05 | Wolfe Research Upgrades Magna International to Peer Perform From Underperform | MT |
Fiscal Period: December | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|---|---|
Revenues | 39.43B | 32.65B | 36.24B | 37.84B | 42.8B | |||||
Total Revenues | 39.43B | 32.65B | 36.24B | 37.84B | 42.8B | |||||
Cost of Goods Sold, Total | 34.02B | 28.21B | 31.1B | 33.19B | 37.18B | |||||
Gross Profit | 5.41B | 4.44B | 5.14B | 4.65B | 5.61B | |||||
Selling General & Admin Expenses, Total | 1.68B | 1.59B | 1.72B | 1.66B | 2.05B | |||||
Depreciation & Amortization - (IS) | 1.34B | 1.37B | 1.51B | 1.42B | 1.44B | |||||
Amortization of Goodwill and Intangible Assets - (IS) | - | - | - | - | 88M | |||||
Other Operating Expenses, Total | 3.03B | 2.95B | 3.23B | 3.08B | 3.57B | |||||
Operating Income | 2.38B | 1.49B | 1.92B | 1.57B | 2.04B | |||||
Interest Expense, Total | -104M | -105M | -122M | -126M | -242M | |||||
Interest And Investment Income | 22M | 19M | 44M | 45M | 86M | |||||
Net Interest Expenses | -82M | -86M | -78M | -81M | -156M | |||||
Income (Loss) On Equity Invest. | 178M | 189M | 148M | 89M | 112M | |||||
Other Non Operating Income (Expenses) | - | - | - | - | - | |||||
EBT, Excl. Unusual Items | 2.48B | 1.59B | 1.99B | 1.58B | 1.99B | |||||
Restructuring Charges | -31M | -212M | -101M | -48M | -148M | |||||
Merger & Related Restructuring Charges | - | - | 100M | - | -23M | |||||
Gain (Loss) On Sale Of Investments | -706M | -315M | -2M | -597M | -217M | |||||
Gain (Loss) On Sale Of Assets | 524M | - | -75M | -58M | - | |||||
Asset Writedown | -43M | -57M | - | - | - | |||||
Other Unusual Items | - | - | 40M | - | - | |||||
EBT, Incl. Unusual Items | 2.22B | 1.01B | 1.95B | 878M | 1.61B | |||||
Income Tax Expense | 591M | 329M | 395M | 237M | 320M | |||||
Earnings From Continuing Operations | 1.63B | 677M | 1.55B | 641M | 1.29B | |||||
Earnings Of Discontinued Operations | - | - | - | - | - | |||||
Net Income to Company | 1.63B | 677M | 1.55B | 641M | 1.29B | |||||
Minority Interest | 133M | 80M | -39M | -49M | -73M | |||||
Net Income - (IS) | 1.76B | 757M | 1.51B | 592M | 1.21B | |||||
Net Income to Common Incl Extra Items | 1.76B | 757M | 1.51B | 592M | 1.21B | |||||
Net Income to Common Excl. Extra Items | 1.76B | 757M | 1.51B | 592M | 1.21B | |||||
Per Share Items | ||||||||||
Net EPS - Basic | 5.61 | 2.53 | 5.04 | 2.04 | 4.24 | |||||
Basic EPS - Continuing Operations | 5.61 | 2.53 | 5.04 | 2.04 | 4.24 | |||||
Basic Weighted Average Shares Outstanding | 315M | 300M | 301M | 290M | 286M | |||||
Net EPS - Diluted | 5.59 | 2.52 | 5 | 2.03 | 4.23 | |||||
Diluted EPS - Continuing Operations | 5.59 | 2.52 | 5 | 2.03 | 4.23 | |||||
Diluted Weighted Average Shares Outstanding | 316M | 300M | 303M | 291M | 287M | |||||
Normalized Basic EPS | 5.35 | 3.58 | 4 | 3.23 | 4.1 | |||||
Normalized Diluted EPS | 5.33 | 3.57 | 3.97 | 3.23 | 4.09 | |||||
Dividend Per Share | 1.5 | 1.63 | 1.74 | 1.81 | 1.86 | |||||
Payout Ratio | 25.44 | 61.69 | 33.95 | 86.82 | 43.03 | |||||
Supplemental Items | ||||||||||
EBITDA | 3.98B | 3.07B | 3.68B | 3.16B | 3.79B | |||||
EBITA | 2.48B | 1.57B | 1.92B | 1.57B | 2.13B | |||||
EBIT | 2.38B | 1.49B | 1.92B | 1.57B | 2.04B | |||||
EBITDAR | 4.35B | 3.44B | 4.05B | 3.56B | 4.18B | |||||
Effective Tax Rate - (Ratio) | 26.59 | 32.7 | 20.28 | 26.99 | 19.93 | |||||
Current Domestic Taxes | 117M | 10M | 63M | 5M | 24M | |||||
Current Foreign Taxes | 467M | 302M | 408M | 452M | 557M | |||||
Total Current Taxes | 584M | 312M | 471M | 457M | 581M | |||||
Deferred Domestic Taxes | 3M | 17M | -4M | -25M | -26M | |||||
Deferred Foreign Taxes | 4M | - | -72M | -195M | -235M | |||||
Total Deferred Taxes | 7M | 17M | -76M | -220M | -261M | |||||
Normalized Net Income | 1.68B | 1.07B | 1.2B | 939M | 1.17B | |||||
Interest on Long-Term Debt | 87M | 105M | 122M | 126M | 162M | |||||
Non-Cash Pension Expense | 19M | 15M | 12M | 12M | 31M | |||||
Supplemental Operating Expense Items | ||||||||||
Research And Development Expense From Footnotes | 640M | 830M | 634M | 649M | 862M | |||||
Net Rental Expense, Total | 368M | 374M | 367M | 395M | 398M | |||||
Imputed Operating Lease Interest Expense | 65.3M | 57.16M | 61.37M | 74.1M | 125M | |||||
Imputed Operating Lease Depreciation | 303M | 317M | 306M | 321M | 273M | |||||
Stock-Based Comp., SG&A Exp. (Total) | - | - | - | - | - | |||||
Total Stock-Based Compensation | - | - | - | - | - |